Next Directions in the Neuroscience of Cancers Arising outside the CNS.

Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
04 Apr 2024
Historique:
medline: 4 4 2024
pubmed: 4 4 2024
entrez: 4 4 2024
Statut: ppublish

Résumé

The field of cancer neuroscience has begun to define the contributions of nerves to cancer initiation and progression; here, we highlight the future directions of basic and translational cancer neuroscience for malignancies arising outside of the central nervous system.

Identifiants

DOI: 10.1158/2159-8290.CD-23-1495 PMID: 38571430
pubmed: 38571430
pii: 741980
doi: 10.1158/2159-8290.CD-23-1495
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

669-673

Informations de copyright

©2024 American Association for Cancer Research.

Auteurs

Moran Amit (M)

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
ORCID: 0000-0002-9720-7766

Corina Anastasaki (C)

Department of Neurology, Washington University, St. Louis, Missouri.
ORCID: 0000-0002-9928-6488

Robert Dantzer (R)

Department of Symptom Research, The University of Texas MD Anderson Cancer Center Houston, Texas.
ORCID: 0000-0001-9399-6107

Ihsan Ekin Demir (IE)

Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, Germany; Neural Influences in Cancer (NIC) International Research Consortium, Munich, Germany.
ORCID: 0000-0001-8241-1871

Benjamin Deneen (B)

Center for Cancer Neuroscience and Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
ORCID: 0000-0002-6335-1081

Karen O Dixon (KO)

Department of Biomedicine, University of Basel, Basel, Switzerland.
ORCID: 0000-0001-7811-5439

Mikala Egeblad (M)

Departments of Cell Biology and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
ORCID: 0000-0002-3371-1445

Erin M Gibson (EM)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California.
ORCID: 0000-0001-9749-3814

Shawn L Hervey-Jumper (SL)

Department of Neurological Surgery and Weill Neuroscience Institute, University of California, San Francisco, San Francisco, California.
ORCID: 0000-0003-4699-260X

Hubert Hondermarck (H)

Cancer Neuroscience Laboratory, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan NSW 2308, Australia.
ORCID: 0000-0003-3807-2985

Claire Magnon (C)

Laboratory of Cancer and Microenvironment-National Institute of Health and Medical Research (INSERM), Institute of Biology François Jacob-Atomic Energy Commission (CEA), University of Paris Cité, University of Paris-Saclay, Paris, France.
ORCID: 0000-0003-2946-5269

Michelle Monje (M)

Department of Neurology and Neurological Sciences, Stanford University, Stanford, California.
Howard Hughes Medical Institute, Stanford, California.
ORCID: 0000-0002-3547-237X

Shorook Na'ara (S)

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
ORCID: 0000-0003-2633-5864

Yuan Pan (Y)

Department of Symptom Research, The University of Texas MD Anderson Cancer Center Houston, Texas.
Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
ORCID: 0000-0002-9465-8289

Elizabeth A Repasky (EA)

Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
ORCID: 0000-0002-9554-4152

Nicole N Scheff (NN)

Hillman Cancer Center, Department of Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
ORCID: 0000-0002-5587-4990

Erica K Sloan (EK)

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Victoria, Australia.
ORCID: 0000-0002-2355-1433

Sebastien Talbot (S)

Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
ORCID: 0000-0001-9932-7174

Kevin J Tracey (KJ)

The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York.
ORCID: 0000-0003-1884-6314

Lloyd C Trotman (LC)

Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
ORCID: 0000-0002-4794-1559

Manuel Valiente (M)

Brain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
ORCID: 0000-0002-0647-7542

Linda Van Aelst (L)

Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
ORCID: 0000-0002-0870-012X

Varun Venkataramani (V)

Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
Department of Functional Neuroanatomy, Institute for Anatomy and Cell Biology, Heidelberg University, Heidelberg, Germany.
ORCID: 0000-0002-2927-0886

Humsa S Venkatesh (HS)

Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts.
ORCID: 0000-0003-1194-3015

Paola D Vermeer (PD)

Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, South Dakota.
ORCID: 0000-0003-2370-8223

Frank Winkler (F)

Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
ORCID: 0000-0003-4892-6104

Richard J Wong (RJ)

Department of Head and Neck Surgery and Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
ORCID: 0000-0001-6259-7314

David H Gutmann (DH)

Department of Neurology, Washington University, St. Louis, Missouri.
ORCID: 0000-0002-3127-5045

Jeremy C Borniger (JC)

Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
ORCID: 0000-0002-5419-0271

Classifications MeSH